Messina Monica, Chiaretti Sabina, Fedullo Anna Lucia, Piciocchi Alfonso, Puzzolo Maria Cristina, Lauretti Alessia, Gianfelici Valentina, Apicella Valerio, Fazi Paola, Te Kronnie Geertruy, Testi Anna Maria, Vitale Antonella, Guarini Anna, Foà Robin
Haematology, Department of Cellular Biotechnologies and Haematology, Policlinico Umberto 1, Sapienza University, Rome, Italy.
GIMEMA Data Center, Rome, Italy.
Br J Haematol. 2017 Aug;178(4):583-587. doi: 10.1111/bjh.14721. Epub 2017 Apr 25.
Copy number aberrations (CNAs) represent cooperating events in B-lineage acute lymphoblastic leukaemia (B-ALL); however, their clinical relevance across different age cohorts is unclear. We analysed the recurrent CNAs in 157 age-stratified B-ALL negative cases for recurrent rearrangements (B-NEG ALL), and their association with patients' clinico-biological features. We found that: (i) CDKN2A/RB1-deleted and EBF1-deleted adults had a shorter disease-free survival than those with wild-type, (ii) among the unfavourable markers, CDKN2A/RB1 deletions and K/NRAS mutations retained their impact in multivariate analysis, encouraging the evaluation of CDKN2A/RB1 deletions and RAS mutations in the diagnostic/prognostic workflow to refine ALL risk assessment.
拷贝数变异(CNAs)是B系急性淋巴细胞白血病(B-ALL)中的协同事件;然而,它们在不同年龄队列中的临床相关性尚不清楚。我们分析了157例按年龄分层的B-ALL阴性病例(B-NEG ALL)中的复发性CNAs,以及它们与患者临床生物学特征的关联。我们发现:(i)CDKN2A/RB1缺失和EBF1缺失的成人患者无病生存期比野生型患者短,(ii)在不良标志物中,CDKN2A/RB1缺失和K/NRAS突变在多变量分析中仍有影响,这促使在诊断/预后工作流程中评估CDKN2A/RB1缺失和RAS突变,以完善ALL风险评估。